Earnings Preview: What To Expect From Charles River Laboratories' Report
With a market cap of $6.7 billion, Charles River Laboratories International, Inc. (CRL) is a global, early-stage contract research organization supporting drug discovery and development. Through its three segments – Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions, the company provides essential products, services, and testing solutions to pharmaceutical, biotechnology, government, ...










